Mrv1909 12231920582D 20 22 0 0 0 0 999 V2000 2.0636 -0.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6511 -0.1105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8886 -0.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0636 0.6039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3012 -0.1105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8886 0.6039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8261 -0.1105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3412 -0.7779 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.3412 0.5569 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4433 -0.5230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4433 0.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8723 0.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1578 0.7144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8723 -0.5230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1578 -0.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3012 -1.5394 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 3.3012 1.3184 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 -2.5867 0.7144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3012 0.3019 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.5867 1.5394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 3 1 2 0 0 0 0 4 2 2 0 0 0 0 5 3 1 0 0 0 0 6 4 1 0 0 0 0 6 5 2 0 0 0 0 8 7 2 0 0 0 0 9 7 1 0 0 0 0 10 8 1 0 0 0 0 11 9 1 0 0 0 0 2 7 1 0 0 0 0 13 12 1 0 0 0 0 14 12 2 0 0 0 0 11 13 2 0 0 0 0 15 14 1 0 0 0 0 10 11 1 0 0 0 0 10 15 2 0 0 0 0 3 16 1 0 0 0 0 6 17 1 0 0 0 0 12 18 1 0 0 0 0 18 19 1 0 0 0 0 18 20 2 0 0 0 0 M END > DB11644 > drugbank > OC(=O)C1=CC=C2N=C(OC2=C1)C1=CC(Cl)=CC(Cl)=C1 > InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19) > TXEIIPDJKFWEEC-UHFFFAOYSA-N > C14H7Cl2NO3 > 308.116 > 306.980298509 > 3 > 27 > -0.999601256172643 > 29.741500360706745 > 1 > 1 > 0 > 1 > 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid > 3.91 > 4.210307916666666 > -3.98 > 0 > -1 > 3 > -1 > 3.6008683518955453 > -0.4045142852966522 > 63.330000000000005 > 84.69049999999997 > 2 > 1 > 3.23e-02 g/l > darolutamide > 0 > DB11644 > approved; investigational > Tafamidis > Tafamidis; Tafamidisum > Vyndamax; Vyndaqel > Tafamidis meglumine $$$$